SUPN   $32.055  -0.11% Market Open

Supernus Pharmaceuticals Inc
Total Cash 347.19M
totalCashPerShare 6.3
EBITDA 125.64M
Total Debt 39.98M
quickRatio 1.619
currentRatio 1.915
Total Revenue 630.16M
debtToEquity 4.175
Revenue/Share 11.508
ROA 0.01947
ROE 0.00558
grossProfits
freeCashflow 219.26M
operatingCashflow 154.86M
earningsGrowth
revenueGrowth 0.242
grossMargins 0.88344
ebitdaMargins 0.19937
operatingMargins 0.10821
profitMargins 0.0083099995
enterpriseValue 1.41B
forwardPE 17.093407
floatShares 47.47M
sharesOutstanding 55.11M
sharesShort 6.67M
sharesShortPriorMonth 6.16M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.05%
heldPercentInstitutions 1.10%
Short Ratio help_outline 14.21%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue 17.394
Price To Book help_outline 1.79
earningsQuarterlyGrowth
netIncomeToCommon 5.24M
trailingEps 0.09%
forwardEps 1.82%
enterpriseToEbitda 11.20
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.44 3Q 2024
institutionsCount 339
lastUpdated Sept. 16, 2024, 12:37 p.m.